Genome-wide brain DNA methylation analysis suggests epigenetic reprogramming in Parkinson disease
Authors:
- Juan I. YoungJYJuan I. Young
- Sathesh K. SivasankaranSSSathesh K. Sivasankaran
- Lily WangLWLily Wang
- Aleena AliAAAleena Ali
- Arpit MehtaAMArpit Mehta
- David A. DavisDDDavid A. Davis
- Derek M. DykxhoornDDDerek M. Dykxhoorn
- Carol K. PetitoCPCarol K. Petito
- Gary W. BeechamGBGary W. Beecham
- Eden R. MartinEMEden R. Martin
- Deborah C. MashDMDeborah C. Mash
- Margaret Pericak-VanceMPMargaret Pericak-Vance
Open Access
- 1 August 2019
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology Genetics
- Vol. 5 (4) , e342
Abstract
Objective Given the known strong relationship of DNA methylation with environmental exposure, we investigated whether brain regions affected in Parkinson disease (PD) were differentially methylated between PD cases and controls. Methods DNA chip arrays were used to perform a genome-wide screen of DNA methylation on the dorsal motor nucleus of the vagus (DMV), substantia nigra (SN), and cingulate gyrus (CG) of pathologically confirmed PD cases and controls selected using the criteria of Beecham et al. Analysis examined differentially methylated regions (DMRs) between cases and controls for each brain area. RNA sequencing and pathway analysis were also performed for each brain area. Results Thirty-eight PD cases and 41 controls were included in the analysis. Methylation studies revealed 234 significant DMR in the DMV, 44 in the SN, and 141 in the CG between cases and controls (Sidak p < 0.05). Pathway analysis of these genes showed significant enrichment for the Wnt signaling pathway (FDR < 0.01). Conclusions Our data suggest that significant DNA methylation changes exist between cases and controls in PD, especially in the DMV, one of the areas affected earliest in PD. The etiology of these methylation changes is not yet known, but the predominance of methylation changes occurring in the DMV supports the hypothesis that vagus nerve function, perhaps involving the gastrointestinal system, is important in PD pathogenesis. These data also give independent support that genes involved in Wnt signaling are a likely factor in the neurodegenerative processes of PD.Keywords
This publication has 51 references indexed in Scilit:
- Implications of DNA Methylation in Parkinson’s DiseaseFrontiers in Molecular Neuroscience, 2017
- DNA methylation in Parkinson's diseaseJournal of Neurochemistry, 2016
- Parkinson's diseaseThe Lancet, 2015
- The genetics of Parkinson's diseaseBritish Medical Bulletin, 2015
- Distinctive patterns of DNA methylation associated with Parkinson diseaseEpigenetics, 2013
- Epigenetic Landscape of Parkinson's Disease: Emerging Role in Disease Mechanisms and Therapeutic ModalitiesNeurotherapeutics, 2013
- Parkinson’s disease and pesticide exposure – a new assessmentCritical Reviews in Toxicology, 2013
- CpG Demethylation Enhances Alpha-Synuclein Expression and Affects the Pathogenesis of Parkinson's DiseasePLOS ONE, 2010
- Methylation Regulates Alpha-Synuclein Expression and Is Decreased in Parkinson's Disease Patients' BrainsJournal of Neuroscience, 2010
- Pesticide exposure and risk of Parkinson's disease: A family-based case-control studyBMC Neurology, 2008